A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Public ClinicalTrials.gov record NCT07753993. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III, Randomized, Double-blind, Parallel-group, Placebo-controlled Multicenter Study to Evaluate the Effect of Elecoglipron in Reducing Renal Outcomes and Mortality in Participants With Chronic Kidney Disease (Elevate-CKD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase III, randomized, double-blind, parallel-group, placebo-controlled multicenter study to investigate outcomes with elecoglipron compared with placebo in participants with CKD with and without T2DM who are on background SGLT2i (dapagliflozin) as GDMT and other SoC treatments for CKD.
Study identification
- NCT ID
- NCT07753993
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 7,000 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 27, 2026
- Primary completion
- Oct 3, 2030
- Completion
- Oct 3, 2030
- Last update posted
- Aug 9, 2026
2026 – 2030
United States locations
- U.S. sites
- 33
- U.S. states
- 19
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Sheffield | Alabama | 35660 | — |
| Research Site | Surprise | Arizona | 85374 | — |
| Research Site | Chula Vista | California | 91910 | — |
| Research Site | Waterbury | Connecticut | 06708 | — |
| Research Site | Chicago | Illinois | 60611 | — |
| Research Site | Topeka | Kansas | 66606 | — |
| Research Site | Beltsville | Maryland | 20705 | — |
| Research Site | Boston | Massachusetts | 02115 | — |
| Research Site | Troy | Michigan | 48098 | — |
| Research Site | Edina | Minnesota | 55435 | — |
| Research Site | Saint Paul | Minnesota | 55117 | — |
| Research Site | Eatontown | New Jersey | 07724 | — |
| Research Site | Albany | New York | 12205 | — |
| Research Site | Buffalo | New York | 14215 | — |
| Research Site | Mineola | New York | 11501 | — |
| Research Site | Morehead City | North Carolina | 28557 | — |
| Research Site | Shelby | North Carolina | 28150 | — |
| Research Site | Statesville | North Carolina | 28625 | — |
| Research Site | Wilmington | North Carolina | 28401 | — |
| Research Site | Wilmington | North Carolina | 28403 | — |
| Research Site | Maumee | Ohio | 43537 | — |
| Research Site | Rapid City | South Dakota | 57701 | — |
| Research Site | Knoxville | Tennessee | 37912 | — |
| Research Site | Morristown | Tennessee | 37813 | — |
| Research Site | Arlington | Texas | 76015 | — |
| Research Site | Dallas | Texas | 75246 | — |
| Research Site | Houston | Texas | 77054 | — |
| Research Site | Lubbock | Texas | 79430 | — |
| Research Site | Mesquite | Texas | 75149 | — |
| Research Site | San Antonio | Texas | 78230 | — |
| Research Site | Shenandoah | Texas | 77384 | — |
| Research Site | South Salt Lake | Utah | 84115 | — |
| Research Site | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 393 non-U.S. sites.
Recently updated Chronic Kidney Disease trials
Other public records listing Chronic Kidney Disease. Sorted by last update posted; newest first. Not a recommendation.
- NCT07793591: Veteran Centered Meal Intervention in Chronic Kidney Disease Not yet recruiting
- NCT07759401: Food As Medicine to Reduce CKD Burden in Health Disparity Populations Not yet recruiting
- NCT07725497: A Study of Luspatercept in People With Anemia Recruiting
- NCT07605390: RAndomized EHR-based Prescribing to Improve Disease-modifying Therapies for Cardio-Kidney-Metabolic Care (RAPID-CKM) Not yet recruiting
- NCT07693543: Nicotinamide Riboside Supplementation in Chronic Kidney Disease Not yet recruiting
- NCT07694544: Renal Impairment Study for Oral EC5026 Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07753993, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 9, 2026 · Synced Aug 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07753993 live on ClinicalTrials.gov.